載入...
Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
Glucocorticoids (GCs) such as dexamethasone (DEX) are administered as cancer co-treatment for palliative purposes due to their pro-apoptotic effects in lymphoid cancer and limited side effects associated with cancer growth and chemotherapy. However, there is emerging evidence that GCs induce therapy...
Na minha lista:
| 發表在: | Int J Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6255064/ https://ncbi.nlm.nih.gov/pubmed/30387838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4616 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|